These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7532546)

  • 1. Clinical relevance of alphafetoprotein microheterogeneity in alphafetoprotein-secreting tumors.
    Saraswathi A; Malati T
    Cancer Detect Prev; 1994; 18(6):447-54. PubMed ID: 7532546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
    Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
    Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors: preliminary study.
    Kinoshita Y; Tajiri T; Souzaki R; Tatsuta K; Higashi M; Izaki T; Takahashi Y; Taguchi T
    J Pediatr Hematol Oncol; 2008 Jun; 30(6):447-50. PubMed ID: 18525461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lectin-binding heterogeneity of alphafetoprotein (AFP). An observation in nude mouse xenografts of endodermal sinus tumors and in pediatric surgical patients.
    Tsuchida Y; Saito S; Kaneko M; Yoshida R; Endo Y
    Oncodev Biol Med; 1983; 4(6):C53-61. PubMed ID: 6196751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical characteristics and clinical applications of alpha-fetoprotein isoforms.
    Seregni E; Botti C; Bombardieri E
    Anticancer Res; 1995; 15(4):1491-9. PubMed ID: 7544570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a Thai referral population.
    Tanwandee T; Setthasin S; Charatcharoenwitthaya P; Chainuvati S; Leelakusolvong S; Pausawasdi N; Srikureja W; Pongprasobchai S; Manatsathit S; Kachintorn U; Ekpo P; Senawong S
    J Med Assoc Thai; 2009 Mar; 92 Suppl 2():S49-56. PubMed ID: 19562986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
    Peng YC; Chan CS; Chen GH
    Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
    Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
    Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
    Kemmer N; Neff G; Kaiser T; Zacharias V; Thomas M; Tevar A; Satwah S; Shukla R; Buell J
    Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.
    Beneduce L; Castaldi F; Marino M; Quarta S; Ruvoletto M; Benvegnù L; Calabrese F; Gatta A; Pontisso P; Fassina G
    Cancer; 2005 Jun; 103(12):2558-65. PubMed ID: 15887222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.
    Tada T; Kumada T; Toyoda H; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kitabatake S; Kuzuya T; Nonogaki K; Shimizu J; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J; Satomura S
    Liver Int; 2005 Aug; 25(4):848-53. PubMed ID: 15998436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
    Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
    Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lectin-reactive alpha-fetoprotein in patients with tyrosinemia type I and hepatocellular carcinoma.
    Baumann U; Duhme V; Auth MK; McKiernan PJ; Holme E
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):77-82. PubMed ID: 16819381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma].
    Sun GZ; Zhao XY; Li JH; Zhao GQ; Wang SX; Kong SL
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1986-8. PubMed ID: 19062741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
    Farinati F; Marino D; De Giorgio M; Baldan A; Cantarini M; Cursaro C; Rapaccini G; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M; Trevisani F
    Am J Gastroenterol; 2006 Mar; 101(3):524-32. PubMed ID: 16542289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-fetoprotein reaction to Pisum sativum agglutinin in differentiation of benign liver diseases from hepatocellular carcinoma.
    Yin ZF; Tu ZX; Cui ZF; Wu MC
    Chin Med J (Engl); 1993 Aug; 106(8):615-8. PubMed ID: 7693403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
    Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
    Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.